Rockwell Medical Inc (RMTI.OQ)
5.00USD
10:35am EDT
$-0.05 (-0.99%)
$5.05
$5.08
$5.08
$4.95
18,143
216,034
$9.50
$3.16
About
Overall
| Beta: | 1.04 |
| Market Cap (Mil.): | $201.58 |
| Shares Outstanding (Mil.): | 39.92 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RMTI.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -2.82 | -- | -- |
| ROI: | -780.23 | 19.48 | 18.76 |
| ROE: | -780.31 | 20.17 | 19.59 |
Rockwell Medical's iron deficiency drug succeeds in trial
- Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease.
Rockwell Medical's iron deficiency drug succeeds in trial
July 11 - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.
Rockwell Medical reports positive data on iron deficiency drug
- Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
UPDATE 1-Rockwell Medical reports positive data on iron deficiency drug
Feb 4 - Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
BRIEF-Rockwell Medical jumps 24 percent in premarket
NEW YORK, Feb 4 - Rockwell Medical Inc : * Shares jump 24 percent in premarket trading after drug trial results
Competitors
| Price | Change | |
|---|---|---|
| DAIICHI SANKYO COMPANY, LIMITED (4568.T) | ¥1,636 | +39.00 |
| Abbott Laboratories (ABT.N) | $36.91 | +0.28 |
| Sanofi SA (SASY.PA) | €76.79 | -3.38 |
| Fresenius Medical Care AG & Co. KGaA (FMEG.DE) | €48.44 | +0.86 |
| Actavis Inc (ACT.N) | $135.43 | +1.16 |
| Galenica AG (GALN.S) | CHF710.00 | +20.00 |
| Cantel Medical Corp. (CMN.N) | $26.81 | +0.27 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

